Access cutting-edge idiopathic hypersomnia treatment through this clinical trial at a research site in Boulder. Study-provided care at no cost to qualified participants.
Access idiopathic hypersomnia specialists in Boulder at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic hypersomnia treatment provided free
This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extended-release oral suspension. The study will enroll subjects who are diagnosed with idiopathic hypersomnia. Subjects will be eligible to enroll regardless of current treatment with oxybate therapy or stimulants/alerting agents at study entry. The estimated total duration of study for each subject is ap
Sponsor: Avadel
Check if you qualify for this idiopathic hypersomnia clinical trial in Boulder, CO
If you're searching for idiopathic hypersomnia treatment options in Boulder, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boulder research site is actively enrolling participants for this clinical trial. You'll receive care from experienced idiopathic hypersomnia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.